Remove 2022 Remove Hypertension Remove Outcomes
article thumbnail

Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.

article thumbnail

Statement on long-term cardiovascular consequences of maternal hypertension: call for urgent action

Heart BMJ

One in five women suffer from hypertension worldwide, and almost half of the mortality in women is caused by cardiovascular disease (CVD) (WHO). The timely launch of the Women’s Health Strategy for England in 2022 focuses attention on the changing health and needs of women across their life.

article thumbnail

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

DAIC

The primary outcome measure for the study is change in six-minute walk distance from Baseline to Week 12. Results of Tenax Therapeutics’ Phase 2 HELP study of levosimendan in patients with pulmonary hypertension (PH) with heart failure with preserved ejection fraction (HFpEF) demonstrated that I.V.

article thumbnail

Predictors of Outcomes in Mild Pulmonary Hypertension

American College of Cardiology

What is the impact on prognosis of the 2022 ESC/ERS pulmonary hypertension (PH) guidelines on the new redefined hemodynamic threshold for the diagnosis of precapillary PH?

article thumbnail

Efficacy of acupuncture for hypertension in the elderly: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Background Hypertension has now developed into a major public health problem worldwide. Objective This study aimed to systematically evaluate the effect of acupuncture alone or in combination with antihypertensive drugs on the efficiency of reducing blood pressure and controlling blood pressure in elderly patients with hypertension.

article thumbnail

Noninvasive evaluation of pulmonary hypertension using the second heart sound parameters collected by a mobile cardiac acoustic monitoring system

Frontiers in Cardiovascular Medicine

Background Pulmonary hypertension (PH) is linked to higher rates of morbidity and mortality worldwide. Methods In the retrospective study, patients admitted to our hospital between January 2022 and April 2023 were classified into PH and control groups using ePASP and compared with acoustic cardiographic parameters.

article thumbnail

Abstract 4138218: Meeting Physical Activity Recommendations Among Wearable Device Users: Insights from the 2022 Health Information National Trends Survey

Circulation

While studies have identified sociodemographic patterns in wearable device usage, little is known about their impact on real-world outcomes, such as increased physical activity.Research Question:Is there a variation in achieving the recommended level of physical activity among wearable device users?Aim:To